Literature DB >> 12220515

Mixed lineage kinase ZAK utilizing MKK7 and not MKK4 to activate the c-Jun N-terminal kinase and playing a role in the cell arrest.

Jaw-Ji Yang1.   

Abstract

The leucine-zipper (LZ) and sterile-alpha motif (SAM) kinase (ZAK) belongs to the MAP kinase kinase kinase (MAP3K) when upon over-expression in mammalian cells activates the JNK/SAPK pathway. The mechanisms by which ZAK activity is regulated are not well understood. Co-expression of dominant-negative MKK7 but not MKK4 and ZAK significantly attenuates JNK/SAPK activation. This result suggests that ZAK activates JNK/SAPK mediated by downstream target, MKK7. Expression of ZAK but not kinase-dead ZAK in 10T1/2 cells results in the disruption of actin stress fibers and morphological changes. Therefore, ZAK activity may be involved in actin organization regulation. Expression of wild-type ZAK increases the cell population in the G(2)/M phase of the cell cycle, which may indicate G(2) arrest. Western blot analysis shows that the decreased cyclin E level correlated strongly with the low proliferative capacity of ZAK-expressed cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220515     DOI: 10.1016/s0006-291x(02)02123-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Hepatic gene networks in morbidly obese patients with nonalcoholic fatty liver disease.

Authors:  Samer Gawrieh; Tesfaye M Baye; Melanie Carless; James Wallace; Richard Komorowski; David E Kleiner; Deborah Andris; Bassem Makladi; Regina Cole; Michael Charlton; Joanne Curran; Thomas D Dyer; Jac Charlesworth; Russell Wilke; John Blangero; Ahmed H Kissebah; Michael Olivier
Journal:  Obes Surg       Date:  2010-12       Impact factor: 4.129

2.  Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK.

Authors:  Harina Vin; Grace Ching; Sandra S Ojeda; Charles H Adelmann; Vida Chitsazzadeh; David W Dwyer; Haiching Ma; Karin Ehrenreiter; Manuela Baccarini; Rosamaria Ruggieri; Jonathan L Curry; Ana M Ciurea; Madeleine Duvic; Naifa L Busaidy; Nizar M Tannir; Kenneth Y Tsai
Journal:  Mol Cancer Ther       Date:  2013-10-29       Impact factor: 6.261

Review 3.  CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss.

Authors:  Rimsha Farooq; Khadim Hussain; Muhammad Tariq; Ali Farooq; Muhammad Mustafa
Journal:  J Appl Genet       Date:  2020-01-07       Impact factor: 3.240

4.  ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.

Authors:  You-Liang Hsieh; Ying-Lan Tsai; Marthandam Asokan Shibu; Chia-Chi Su; Li-Chin Chung; Peiying Pai; Chia-Hua Kuo; Yu-Lan Yeh; Vijaya Padma Viswanadha; Chih-Yang Huang
Journal:  Mol Cell Biochem       Date:  2015-04-14       Impact factor: 3.396

5.  ZAK induces MMP-2 activity via JNK/p38 signals and reduces MMP-9 activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast cells.

Authors:  Yi-Chang Cheng; Wei-Wen Kuo; Hsi-Chin Wu; Tung-Yuan Lai; Chun-Hsien Wu; Jin-Ming Hwang; Wen-Hong Wang; Fuu-Jen Tsai; Jaw-Ji Yang; Chih-Yang Huang; Chun-Hsien Chu
Journal:  Mol Cell Biochem       Date:  2009-01-28       Impact factor: 3.396

6.  Silencing of the JNK pathway maintains progesterone receptor activity in decidualizing human endometrial stromal cells exposed to oxidative stress signals.

Authors:  Beatriz Leitao; Marius C Jones; Luca Fusi; Jenny Higham; Yun Lee; Masashi Takano; Tomoko Goto; Mark Christian; Eric W-F Lam; Jan J Brosens
Journal:  FASEB J       Date:  2009-12-21       Impact factor: 5.191

7.  Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotype.

Authors:  Mahesh Ramamoorthy; Peter Sykora; Morten Scheibye-Knudsen; Christopher Dunn; Cindy Kasmer; Yongqing Zhang; Kevin G Becker; Deborah L Croteau; Vilhelm A Bohr
Journal:  Free Radic Biol Med       Date:  2012-08-03       Impact factor: 7.376

8.  Structure of the Human Protein Kinase ZAK in Complex with Vemurafenib.

Authors:  Sebastian Mathea; Kamal R Abdul Azeez; Eidarus Salah; Cynthia Tallant; Finn Wolfreys; Rebecca Konietzny; Roman Fischer; Hua Jane Lou; Paul E Brennan; Gisela Schnapp; Alexander Pautsch; Benedikt M Kessler; Benjamin E Turk; Stefan Knapp
Journal:  ACS Chem Biol       Date:  2016-03-31       Impact factor: 5.100

9.  RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player.

Authors:  K Häbig; M Walter; S Poths; O Riess; M Bonin
Journal:  Neurogenetics       Date:  2007-12-21       Impact factor: 2.660

10.  ZAK negatively regulates RhoGDIbeta-induced Rac1-mediated hypertrophic growth and cell migration.

Authors:  Chih-Yang Huang; Li-Chiu Yang; Kuan-Yu Liu; I-Chang Chang; Pao-Hsin Liao; Janet Ing-Yuh Chou; Ming-Yung Chou; Wei-Wen Lin; Jaw-Ji Yang
Journal:  J Biomed Sci       Date:  2009-06-18       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.